MYLAN FE 134 MYLAN FE 134 (Fenofibrate (micronized) 134 mg)

Pill imprint MYLAN FE 134 MYLAN FE 134 has been identified as Fenofibrate (micronized) 134 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibrate (micronized)

Imprint:

MYLAN FE 134 MYLAN FE 134

Strength:

134 mg

Color:

Orange & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-8629

Inactive Ingredients:

silicon dioxide
corn starch
croscarmellose sodium
D&C Yellow No. 10
FD&C Yellow No. 6
gelatin
lactose
magnesium stearate
povidone
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
potassium hydroxide
propylene glycol
shellac
ammonia

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.